Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 8

Results For "World-Health-Organization"

128 News Found

Challenges of Thalassemia management in India bring like-minded stakeholders together
Public Health | May 08, 2022

Challenges of Thalassemia management in India bring like-minded stakeholders together

Ahead of International Thalassemia Day on 8th May, medical professionals and representatives of patient bodies participated in a virtual discussion on the current situation of Thalassemia management in India


14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021
News | May 05, 2022

14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021

The report has estimated 4.74 million deaths for India in 2020 and 2021,


Foundation S: Sanofi’s new philanthropic spearhead
Sustainability | May 04, 2022

Foundation S: Sanofi’s new philanthropic spearhead

Foundation S will incorporate as its cornerstone initiative the former Sanofi Espoir Foundation’s ‘My Child Matters’ program in childhood cancer


Global AYUSH meet ends with promise of Rs 9000 cr. in investment
News | April 25, 2022

Global AYUSH meet ends with promise of Rs 9000 cr. in investment

Investment and innovation opportunities in the field of AYUSH are limitless : Sarbananda Sonowal


WHO report highlights the role of traditional Chinese medicine in the treatment of Covid-19
News | April 19, 2022

WHO report highlights the role of traditional Chinese medicine in the treatment of Covid-19

The report pointed out that in the process of treating Covid-19, there are promising data to suggest that TCM is beneficial in reducing the risk of progression from mild-to-moderate cases to severe Covid-19


PM Narendra Modi lays down five goals for new WHO Global Centre
News | April 19, 2022

PM Narendra Modi lays down five goals for new WHO Global Centre

Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine


Moderna kickstarts Phase 1/2 study for influenza vaccine candidate
Biotech | April 11, 2022

Moderna kickstarts Phase 1/2 study for influenza vaccine candidate

Both mRNA-1020 and mRNA-1030 target hemagglutinin and neuraminidase antigens, two major influenza surface glycoproteins that are essential across the viral life cycle


CanSinoBIO's Covid-19 mRNA vaccine receives clinical trial approval in China
Biotech | April 04, 2022

CanSinoBIO's Covid-19 mRNA vaccine receives clinical trial approval in China

CanSinoBIO will continue to focus on developing a variety of innovative preventive vaccines in its diversified product pipeline with proprietary technologies, including the inhaled version of its COVID-19 vaccine, Convidecia


USFDA grants priority review to Roche’s Actemra/RoActemra to treat Covid-19
News | April 04, 2022

USFDA grants priority review to Roche’s Actemra/RoActemra to treat Covid-19

If approved, it will be the first USFDA-approved immunomodulator for the treatment of Covid-19 in hospitalised patients


WHO suspends supply of Covaxin under Covax facility
News | April 03, 2022

WHO suspends supply of Covaxin under Covax facility

WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility